Skip to main content
OXFORD BIODYNAMICS PLC logo

OXFORD BIODYNAMICS PLC — Investor Relations & Filings

Ticker · OBD ISIN · GB00BD5H8572 LEI · 2138005Y1TK258O5U928 IL Professional, scientific and technical activities
Filings indexed 416 across all filing types
Latest filing 2020-10-28 Regulatory Filings
Country GB United Kingdom
Listing IL OBD

About OXFORD BIODYNAMICS PLC

https://www.oxfordbiodynamics.com/

Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests. The company's proprietary EpiSwitch® platform utilizes 3D genomics and epigenetic biomarkers to create diagnostic solutions for life-changing diseases, with a focus on oncology. Its portfolio of clinical tests includes the EpiSwitch® PSE, a blood test that assesses the likelihood of prostate cancer with high accuracy to help reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test designed to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. The platform enables the translation of 3D genome regulation into clinical applications for precision medicine at scale.

Recent filings

Filing Released Lang Actions
Disease severity program for COVID-19 advances
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and contains a date (28 October 2020) and company information (Oxford BioDynamics Plc). The content describes a business development update regarding a collaboration with Oregon Health & Science University (OHSU) to advance a COVID-19 severity test using the EpiSwitch™ platform. This type of announcement, which details operational progress, partnerships, and scientific updates, is characteristic of a general regulatory news service release. Since it is not a formal financial report (like 10-K or IR), a specific management disclosure (like MANG or DIRS), or a dedicated announcement of a report (like RPA), the most appropriate general category for a standard regulatory news service release is 'Regulatory Filings' (RNS). The document length (8070 chars) is substantial enough that it is the primary announcement itself, not just a brief notice of publication.
2020-10-28 English
PDMR Dealing / Grant of Share Options
Remuneration Information Classification · 99% confidence The document begins with 'RNS Number : 3190S' and contains a detailed notification regarding the 'Grant of Share Options' to a Non-Executive Chairman (PDMR Dealing). This type of mandatory disclosure concerning insider transactions (director/executive share dealings) is typically classified under 'Director's Dealing' (DIRS). Although it is distributed via RNS, the specific content points directly to DIRS, which is a more precise classification than the general RNS fallback.
2020-07-08 English
PDMR Dealing
Director's Dealing Classification · 100% confidence The document explicitly starts with 'RNS Number : 5604R' and contains details about a transaction by a Person Discharging Managerial Responsibilities (PDMR) concerning the acquisition of ordinary shares by the Non-Executive Chairman. This type of insider transaction disclosure, mandated by regulations like the EU Market Abuse Regulation, is typically reported via regulatory news services. The presence of the RNS header and the specific content (Director's Dealing) strongly points towards a regulatory announcement. While 'DIRS' (Director's Dealing) is a specific category, the document is presented as a general regulatory news service release ('RNS Number', 'This information is provided by RNS'). Given the options, 'DIRS' is the most precise classification for the *content* (insider trade), but since the document format is a standard RNS release detailing insider dealing, and 'DIRS' is available, I will select 'DIRS'. If 'DIRS' were not available, 'RNS' would be the fallback for the format.
2020-06-30 English
PDMR Dealing
Director's Dealing Classification · 100% confidence The document begins with an 'RNS Number' and is dated June 23, 2020. The content explicitly details a 'PDMR Dealing' (Persons Discharging Managerial Responsibilities) transaction, specifically an 'Acquisition of ordinary shares' by a Non-Executive Director's controlled fund. This type of insider transaction report, mandated by regulations like the EU Market Abuse Regulation, falls directly under the category of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content is about insider trades, making DIRS the most precise classification.
2020-06-23 English
PDMR Dealing
Director's Dealing Classification · 100% confidence The document is identified by the 'RNS Number' header and explicitly mentions 'RNS Number : 1593Q' and 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a transaction where the Chief Financial Officer, Paul Stockdale, purchased company shares. This type of insider transaction disclosure, especially when referencing EU Market Abuse Regulation, falls under the category of Director's Dealing (DIRS). Although it is an RNS announcement, the specific nature of the content (PDMR Dealing) makes DIRS a more precise classification than the general RNS fallback.
2020-06-17 English
Interim results for six months ended 31 March 2020
Interim / Quarterly Report Classification · 95% confidence The document is an 'Interim Results' announcement for the six-month period ended 31 March 2020. It contains financial highlights (revenue, operating loss, cash position), operational updates, and management commentary. While it is an announcement of results, it provides substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). It is not merely a notice of publication (RPA) as it contains the actual financial figures and detailed management review. H1 2020
2020-06-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.